scholarly journals 2021 ASCO Annual Meeting: Takeaways for the Advanced Practitioner

2021 ◽  
Vol 12 (6) ◽  
Author(s):  
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN
Keyword(s):  
Cancer Research ◽  
Access To Care ◽  
Precision Medicine ◽  
Annual Meeting ◽  
Special Issue ◽  
Virtual Meeting ◽  
Advanced Practitioner ◽  
American Society

Welcome to our special issue on highlights from the 2021 American Society of Clinical Oncology’s (ASCO) Annual Meeting, which was ASCO’s second virtual meeting. Taking place from June 4 to 8, 2021, the ASCO Annual Meeting connected around 42,700 attendees from 138 countries to discuss the latest developments in cancer research. These included advances in the treatment of prostate, breast, lung, and renal cancers as well as screening, prevention, access to care, immunotherapy, and precision medicine.

American Society of Clinical Oncology (ASCO) - 56th Annual Meeting. Virtual Meeting - May 29-31, 2020

2020 ◽  
Vol 45 (8) ◽  
pp. 538
Author(s):  
P. De las Heras Prat ◽  
N. Diaz Santamaria ◽  
I. Rivera Líbano
Keyword(s):  
Annual Meeting ◽  
Clinical Oncology ◽  
Virtual Meeting ◽  
American Society

scholarly journals How technology can help you to survive a meeting

2008 ◽  
Author(s):  
Martin Fenner
Keyword(s):  
Cancer Research ◽  
Annual Meeting ◽  
Clinical Oncology ◽  
Clinical Cancer Research ◽  
Specific Research ◽  
Clinical Cancer ◽  
American Society

I'm currently in Chicago at the annual meeting of the American Society of Clinical Oncology (ASCO). This is a large meeting on clinical cancer research with about 30.000 people attending. Rather than writing about the specific research presented and discussed at the meeting, ...

scholarly journals Disparities and Access to Care: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner

2021 ◽  
Vol 12 (6) ◽  
Author(s):  
Amy Pierre, MSN, ANP-BC
Keyword(s):  
Access To Care ◽  
Annual Meeting ◽  
Cancer Center ◽  
Precision Oncology ◽  
Minority Representation ◽  
Advanced Practitioner

Amy Pierre, MSN, ANP-BC, of Flatiron Health and Memorial Sloan Kettering Cancer Center, considers takeaways from a program targeting minority accrual to oncology trials and a study evaluating minority representation in precision oncology trials.

Sign in / Sign up

Export Citation Format

Share Document